MetaADEDB 2.0 @ LMMD
Hypoaldosteronism
(UMLS:C0020595)
Definition:
A congenital or acquired condition of insufficient production of ALDOSTERONE by the ADRENAL CORTEX leading to diminished aldosterone-mediated synthesis of Na(+)-K(+)-EXCHANGING ATPASE in renal tubular cells. Clinical symptoms include HYPERKALEMIA, sodium-wasting, HYPOTENSION, and sometimes metabolic ACIDOSIS.
UMLS ID:
C0020595
MeSH ID:
D006994
Classification:
Name:
Endocrine System Diseases
MeSH Tree Number(s):
C19.053.500.480
Synonym(s)
1.
Hypoaldosteronism
2.
Aldosterone Deficiency
3.
Aldosterone deficiency
4.
Aldosterone deficiency syndrome
5.
Aldosterone deficiency, NOS
6.
HYPOALDOSTERONISM
7.
Hypoaldosteronemia
8.
Mineralocorticoid Deficiency
9.
Unspecified adrenocortical insufficiency
10.
aldosterone deficiency
11.
hypoadrenalism
12.
hypoaldosteronism
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1CarbamazepineFAERS: 6US FAERS
2reviparinFAERS: 410726030CTD
US FAERS
3FurosemideFAERS: 3US FAERS
4DexamethasoneFAERS: 2US FAERS
5ItraconazoleFAERS: 2US FAERS
6Trimethoprim, Sulfamethoxazole Drug CombinationFAERS: 2US FAERS
7BudesonideFAERS: 1US FAERS
8CelecoxibFAERS: 1US FAERS
9CyclosporineFAERS: 1US FAERS
10DiclofenacFAERS: 1US FAERS
11EtodolacFAERS: 1US FAERS
12LinezolidFAERS: 1US FAERS
13LisinoprilFAERS: 1US FAERS
14MethylphenidateFAERS: 1US FAERS
15pimecrolimusFAERS: 1US FAERS
16BenzbromaroneOFFSIDES
17Glycyrrhizic AcidOFFSIDES
18Indomethacin3375885
6814155
CTD
19Mitomycin8061399CTD
20Naproxen3375885CTD
21sarpogrelateOFFSIDES
Similar ADE(s)
NameSemantic Similarity
1Addison Disease31.8%
2Primary Adrenal Insufficiency31.8%
3Adrenal Cortex Diseases31%
4Adrenal Gland Neoplasms20.7%
5Cushing Syndrome20%
6Hyperaldosteronism20%
7Gonadal Disorders18.5%
8Parathyroid Diseases18.5%
9Thyroid Diseases18.5%
10Bone Diseases, Endocrine12.2%
11Endocrine Gland Neoplasms12.2%
12Diabetes Mellitus11.9%
13Pituitary Diseases11.8%
14Adrenocortical carcinoma11.3%
15Euthyroid Sick Syndromes10.3%
16Goiter10.3%
17Hyperparathyroidism10.3%
18Hyperthyroidism10.3%
19Hyperthyroxinemia10.3%
20Hypogonadism10.3%
21Hypoparathyroidism10.3%
22Hypothyroidism10.3%
23Delayed Puberty10.3%
24Precocious Puberty10.3%
25Thyroiditis10.3%
26Hypogonadotropic hypogonadism10.3%
27Testotoxicosis10.3%
28Secondary hypothyroidism10.3%
29Primary Hyperthyroidism10.3%
30Primary Hypothyroidism10.3%
31Waterhouse-Friderichsen Syndrome9%
32Dwarfism8.9%
33Parathyroid Neoplasms8.2%
34Thyroid Neoplasm8.2%
35Thyroid carcinoma8.2%
36Testicular Diseases7%
37Ovarian Diseases6.7%
38Empty Sella Syndrome6.7%
39Hyperpituitarism6.7%
40Hypopituitarism6.7%
41Hypophysitis6.7%
42Hyperparathyroidism, Secondary6.7%
43Thyrotoxicosis6.7%
44Hyperparathyroidism, Primary6.7%
45Thyroid Hormone Resistance Syndrome6.7%
46Congenital Hypothyroidism5.6%
47ovarian neoplasm5.5%
48Graves Disease5.4%
49Adrenoleukodystrophy5.3%
50Thyroid Nodule5.3%
51Gestational Diabetes5.1%
52Latent Autoimmune Diabetes in Adults5.1%
53Diabetes Insipidus5%
54Diabetes Mellitus, Experimental5%
55Hyperglycemic Hyperosmolar Nonketotic Coma4.9%
56Hashimoto Disease4.9%
57Testicular Neoplasms4.8%
58Diabetic Angiopathies4.5%
59Autoimmune thyroiditis4.5%
60Diabetic Neuropathies4.4%
61Myxedema4.4%
62Orchitis4.4%
63Diabetic Amyotrophy4.4%
64Diabetic Autonomic Neuropathy4.4%
65Diabetic Cardiomyopathies4.4%
66Pituitary Adenoma4.4%
67Pituitary Neoplasms4.4%
68Ovarian Hyperstimulation Syndrome4.4%
69Hyperprolactinemia4.4%
70Prolactinoma4.4%
71Growth Hormone-Secreting Pituitary Adenoma4.4%
72Hermaphroditism4.1%
73Disorders of Sex Development4.1%
74Pituitary Apoplexy3.9%
75Diabetic Foot3.9%
76Nelson Syndrome3.9%
77Multiple Endocrine Neoplasia3.4%
78Pancreatic Neoplasm3.4%
79Corpus Luteum Cyst3.3%
80Ovarian Cysts3.3%
81Gigantism3.3%
82Diabetic Nephropathy3.3%
83Kallmann Syndrome3.3%
84Acromegaly3.3%
85Anovulation3.3%
86Diabetic Ketoacidosis3.3%
87Oophoritis3.3%
88granulosa cell tumor3.2%
89Carcinoma, Ovarian Epithelial3.2%
90Klinefelter Syndrome2.8%
91Cryptorchidism2.7%
92Gonadal Dysgenesis2.6%
93Adrenogenital Syndrome2.6%
94Ovotesticular Disorders of Sex Development2.6%
95Diabetic Retinopathy2.5%
96Polycystic Ovary Syndrome2.4%
97Leydig Cell Tumor2.2%
98Multiple Endocrine Neoplasia Type 12.2%
99Hyperandrogenism2.1%
100Carcinoma, Pancreatic Ductal1.6%
101Turner Syndrome1.4%
102insulinoma1.4%
103Gastrinoma1.4%
104Glucagonoma1.4%
105Carcinoma, Endometrioid1.4%
106Renal Osteodystrophy1.2%
107Renal rickets1.2%
108Vipoma1.2%
109Denys-Drash Syndrome0.7%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.